Quantitative analysis for Zai Lab Limited (ZLAB) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (56.0) (grade B). Gem alpha score: 35.0. 30 signals analyzed (25 differentiated alt-data).
ZLAB stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $21.77 | $20.56 | $20.75 |
| 2026-05-11 | $21.09 | $19.31 | $19.59 |
| 2026-05-21 | $19.18 | $18.38 | $19.10 |
| 2026-06-03 | $17.28 | $16.81 | $17.17 |
| 2026-06-15 | $18.06 | $17.57 | $17.73 |
| 2026-06-26 | $18.22 | $17.23 | $18.00 |
| 2026-07-09 | $20.31 | $19.66 | $19.98 |
| 2026-07-21 | $20.90 | $20.19 | $20.48 |
| 2026-07-31 | $18.77 | $17.97 | $18.27 |
| 2026-08-12 | $25.77 | $25.00 | $25.49 |
| 2026-08-24 | $25.96 | $25.25 | $25.64 |
| 2026-09-03 | $27.14 | $26.32 | $27.00 |
How Zai Lab Limited stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | $2.1B | 65.0 |
| ESTA | Establishment Labs Holdings Inc. | $2.1B | — |
| BHC | Bausch Health Companies Inc. | $2.1B | 33.0 |
| PHVS | Pharvaris N.V. | $1.9B | 72.0 |
View all Health Care stocks by valuation and signals →
Zai Lab Limited (ZLAB) scores Buy (56.0), and the composite conceals a 80-point disagreement between its dimensions. It is strongest on competitive moat at 99 and ML forecast at 98, and weakest on AI Alpha (gem) at 19. A stock can carry competitive moat that high while AI Alpha (gem) sits at 19; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 99 |
| ML forecast | 98 |
| analyst consensus | 82 |
| technicals | 47 |
| AI Alpha (gem) | 19 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Zai Lab Limited (ZLAB): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/ZLAB"><img src="https://stoquant.com/badge/ZLAB.svg" alt="Zai Lab Limited (ZLAB) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.